On the contrary, the expression level of TRPV4 is significantly reduced in advanced endothelial and skin cancers [211,217], suggesting that TRPV4 exhibits both oncogenic or tumour suppressor effects depend on the cancer type [218]. The gene discussed is TRPV4; the disease is skin neoplasm.